公司概覽
業務類別 Biotechnology
業務概覽 Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
公司地址 280 East Grand Avenue, South San Francisco, CA, USA, 94080
電話號碼 +1 650 231-6625
傳真號碼 --
公司網頁 https://www.alumis.com
員工數量 170
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Martin Babler Chairman of the Board, President and Chief Executive Officer 美元 605.90K 16/06/2025
Mr. Derrick Richardson Senior Vice President, People and Culture -- 16/06/2025
Mr. Mark Bradley Chief Development Officer -- 16/06/2025
Dr. Jorn Drappa, M.D.,PhD Chief Medical Officer -- 16/06/2025
Mr. John R. Schroer Chief Financial Officer and Principal Accounting Officer -- 16/06/2025
Dr. David M. Goldstein, PhD Chief Scientific Officer 美元 466.50K 16/06/2025
Mr. Roy C. Hardiman Chief Business and Strategy Officer 美元 444.30K 16/06/2025
Ms. Sara Klein Chief Legal Officer and Corporate Secretary -- 16/06/2025
 
董事會成員
董事會 職務 更新日期
Mr. Martin Babler Chairman of the Board, President and Chief Executive Officer 16/06/2025
Ms. Lynn A. Tetrault, J.D. Independent Director 21/05/2025
Dr. James B. Tananbaum,M.D. Independent Director 16/06/2025
Mr. Patrick C. Machado, J.D. Independent Director 16/06/2025
Dr. Sapna Srivastava, PhD Independent Director 16/06/2025
Dr. Srinivas Akkaraju, M.D.,PhD Independent Director 16/06/2025
Dr. Alan B. Colowick, M.D.,M.P.H. Independent Director 16/06/2025
Dr. Zhengbin Yao, PhD Independent Director 16/06/2025
 
所屬ETF (更新日期: 07/03/2026 04:27)
代號 名稱 佔比% 持有日期
URTYProShares UltraPro Russell20000.003%27/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.002%25/02/2026
ITWOProShares Russell 2000 High Income ETF0.002%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.002%28/02/2026
DFAUDimensional US Core Equity Market ETF0.0005%27/02/2026
TNXTT. Rowe Price Innovation Leaders ETF0.0005%28/02/2026
KBFRInnovator U.S. Small Cap Mgd 10 Bfr ETF0.0002%27/02/2026
AVSUAvantis Responsible US Equity ETF0.00005%28/02/2026
HDGProShares Hedge Replication0.00005%27/02/2026
AVTMAvantis Total Equity Markets ETF0.00001%28/02/2026
DFATDimensional US Targeted Value ETF<0.000001%27/02/2026
IWOiShares Russell 2000 Growth ETF<0.000001%27/06/2025
VTWGVanguard Russell 2000 Growth ETF<0.000001%30/06/2025
  1   2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.